Bridging the Gap From API to Pharmaceutical Formulations
Avivia has four integrated platforms:
Bridging the Gap From API to Pharmaceutical Formulations
Avivia has four integrated platforms:
Formulation Development
Analytical Services
Dissolution Methods
Excipent Analysis
Formulation Development
From API to Product!
Our comprehensive R&D formulation capabilities combined with our tightly integrated analytical expertise, allow us to support you in advancing your pharmaceutical innovations. Our services leverage a multidisciplinary approach to design formulations, taking into account factors such as bioavailability, stability, and manufacturing scalability.
Our knowledge spans a wide range of medicinal dosage forms, providing not only cutting-edge solutions but also tailored problem-solving and troubleshooting strategies.
As we are CMO independent, we select the best manufacturing facility for your product.
From reverse engineering, through in-depth research and development, up to small-scale GMP batch manufacturing, we are dedicated to accelerating your product’s journey to market. Partner with Avivia to streamline your drug development process and achieve faster, more efficient outcomes.
Analytical Services
Dissolving your Challenges!
Avivia’s laboratory specializes in delivering comprehensive analytical services crucial for informed decision-making in drug development. We can support you in complex product characterisation, reverse engineering, competitor analysis, troubleshooting and challenging method development.
Our expert team employs a diverse array of state-of-the-art techniques, including chromatography, spectroscopy, mass spectrometry, and more, to ensure the quality, safety, and efficacy of pharmaceutical products. When the time is there we take care of the analytical method transfer to a qualified lab of choice for the final quality testing.
Dissolution Methods
More than a QC test!
For us, dissolution testing is far from a routine test, it is an essential tool in guiding pharmaceutical formulation development. Small multidisciplinary teams integrate dissolution test observations with pharmaceutical development discussions and clinical data, offering valuable insights into formulation factors and leading to more informed decision-making.
Our highly skilled team is dedicated to developing advanced predictive and biorelevant methods, empowering you to make well-informed R&D choices. These sophisticated methods allow our customers to proceed with clinical testing with confidence. We provide a complete range of dissolution apparatus, from Apparatus I and II to the more advanced Apparatus III and IV.
Excipent Analysis
For whats not on the COA!
Excipients are essential to pharmaceutical formulations, influencing everything from stability to bioavailability. However, since many excipients are derived from natural sources, they often exhibit variability in purity, reactivity, and functionality across different suppliers and even between batches. These inconsistencies can make it challenging to maintain control over product performance and safety.
Excipia is an excipient characterisation and research service platform, focused on excipient quantification and ensuring your excipients are of the right quality. We use our experience, propitiatory expertise and state of the art facilities to physicochemically characterize excipents, identify critical functional attributes and guarantee the stability and efficacy of your drug products.
Formulation Development
From API to Product!
Our comprehensive R&D formulation capabilities combined with our tightly integrated analytical expertise, allow us to support you in advancing your pharmaceutical innovations. Our services leverage a multidisciplinary approach to design formulations, taking into account factors such as bioavailability, stability, and manufacturing scalability.
Our knowledge spans a wide range of medicinal dosage forms, providing not only cutting-edge solutions but also tailored problem-solving and troubleshooting strategies.
As we are CMO independent, we select the best manufacturing facility for your product.
From reverse engineering, through in-depth research and development, up to small-scale GMP batch manufacturing, we are dedicated to accelerating your product’s journey to market. Partner with Avivia to streamline your drug development process and achieve faster, more efficient outcomes.
Analytical Services
Dissolving your Challenges!
Avivia’s laboratory specializes in delivering comprehensive analytical services crucial for informed decision-making in drug development. We can support you in complex product characterisation, reverse engineering, competitor analysis, troubleshooting and challenging method development.
Our expert team employs a diverse array of state-of-the-art techniques, including chromatography, spectroscopy, mass spectrometry, and more, to ensure the quality, safety, and efficacy of pharmaceutical products. When the time is there we take care of the analytical method transfer to a qualified lab of choice for the final quality testing.
Dissolution Methods
More than a QC test!
For us, dissolution testing is far from a routine test, it is an essential tool in guiding pharmaceutical formulation development. Small multidisciplinary teams integrate dissolution test observations with pharmaceutical development discussions and clinical data, offering valuable insights into formulation factors and leading to more informed decision-making.
Our highly skilled team is dedicated to developing advanced predictive and biorelevant methods, empowering you to make well-informed R&D choices. These sophisticated methods allow our customers to proceed with clinical testing with confidence. We provide a complete range of dissolution apparatus, from Apparatus I and II to the more advanced Apparatus III and IV.
Excipient Analysis
For whats not on the COA!
Excipients are essential to pharmaceutical formulations, influencing everything from stability to bioavailability. However, since many excipients are derived from natural sources, they often exhibit variability in purity, reactivity, and functionality across different suppliers and even between batches. These inconsistencies can make it challenging to maintain control over product performance and safety.
Excipia is an excipient characterisation and research service platform, focused on excipient quantification and ensuring your excipients are of the right quality. We use our experience, propitiatory expertise and state of the art facilities to physicochemically characterize excipents, identify critical functional attributes and guarantee the stability and efficacy of your drug products.
Avivia for all
Our diverse customer base spans across Big Pharma, specialty pharma, emerging drug development firms, generic drug companies, universities, excipient manufacturers, law firms, and venture capital firms. While our core expertise lies in wet-lab product development, we also offer hands-on support in areas like IP protection, investor due diligence, upscaling, deformulation analysis, and life cycle management strategy.
By serving a broad range of industries with unique needs, we continuously grow stronger and more versatile in meeting your challenges.
Whether it’s protecting or creating new formulation patents for originator products, or navigating established patents for generic drug development, we continuously pursue innovative IP opportunities to maximize product value. Our team holds over 30 granted patents across a diverse range of drug products.
Patents are in our DNA!
IP creation, protection and evasion
Avivia in numbers
“Welcome to Avivia! We hope we’ve sparked your interest. Explore our Services and Lab Capabilities sections to discover how we support pharmaceutical, generics, and drug development companies. If you’d like to learn more, feel free to reach out—we’re here to help accelerate your development programs!”
Lee Ayres, Managing Director Avivia BV
Avivia for all
Our diverse customer base spans across Big Pharma, specialty pharma, emerging drug development firms, generic drug companies, universities, excipient manufacturers, law firms, and venture capital firms. While our core expertise lies in wet-lab product development, we also offer hands-on support in areas like IP protection, investor due diligence, upscaling, deformulation analysis, and life cycle management strategy.
By serving a broad range of industries with unique needs, we continuously grow stronger and more versatile in meeting your challenges.
IP creation, protection and evasion
Whether it’s protecting or creating new formulation patents for originator products, or navigating established patents for generic drug development, we continuously pursue innovative IP opportunities to maximize product value. Our team holds over 30 granted patents across a diverse range of drug products. Patents are in our DNA!
Avivia in numbers
“Welcome to Avivia! We hope we’ve sparked your interest. Explore our Services and Lab Capabilities sections to discover how we support pharmaceutical, generics, and drug development companies. If you’d like to learn more, feel free to reach out—we’re here to help accelerate your development programs!”
Lee Ayres, Managing Director Avivia BV
